Erasca Inc (ERAS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ERAS | CRSP | LEGN | ||
| Company | Erasca Inc | Crispr Therapeutics Ag | Legend Biotech Corp ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 17.86 | 56.18 | 30.07 | ||
| High | 18.49 | 61.68 | 30.27 | ||
| Low | 17.24 | 56.18 | 29.56 | ||
| Latest | 18.47 | 60.08 | 29.91 | ||
| Change | +0.55 | +4.46 | +0.02 | ||
| % Change | +3.07% | +8.02% | +0.07% | ||
| Volume | 4,096,100 | 2,931,600 | 1,407,000 | ||
| 20-Day Average Volume | 6,014,700 | 1,786,700 | 2,700,845 | ||
| Previous Close | 17.92 | 55.62 | 29.89 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 14.88 | 53.53 | 31.62 | ||
| 20-Day Raw Stochastic | 99.70% | 87.36% | 26.34% | ||
| 20-Day Relative Strength | 66.97 | 62.01 | 51.23 | ||
| Weighted Alpha | +1,182.82 | +16.56 | -0.67 | ||
| Today's Opinion | 88% Buy | 40% Buy | 64% Buy | ||
| Previous Opinion | 88% Buy | 40% Buy | 64% Buy | ||
| Last Month's Opinion | 40% Buy | 64% Sell | 72% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +23.55% since 06/25/26 | +11.30% since 06/25/26 | +5.21% since 06/25/26 | ||
| Low | 14.72 on 06/26/26 | 53.31 on 06/26/26 | 27.77 on 06/29/26 | ||
| High | 18.49 on 07/02/26 | 61.68 on 07/02/26 | 30.27 on 07/02/26 | ||
| 1-Month | |||||
| %Chg | +37.02% since 06/02/26 | +15.49% since 06/02/26 | -17.56% since 06/02/26 | ||
| Low | 11.81 on 06/05/26 | 49.02 on 06/11/26 | 27.43 on 06/18/26 | ||
| High | 18.49 on 07/02/26 | 61.68 on 07/02/26 | 37.50 on 06/03/26 | ||
| 3-Month | |||||
| %Chg | +3.71% since 04/02/26 | +21.35% since 04/02/26 | +56.27% since 04/02/26 | ||
| Low | 8.70 on 04/28/26 | 46.92 on 05/19/26 | 17.64 on 04/13/26 | ||
| High | 24.28 on 04/23/26 | 61.68 on 07/02/26 | 37.50 on 06/03/26 | ||
| 6-Month | |||||
| %Chg | +414.48% since 01/02/26 | +11.74% since 01/02/26 | +39.05% since 01/02/26 | ||
| Low | 3.36 on 01/05/26 | 44.12 on 03/30/26 | 16.24 on 02/04/26 | ||
| High | 24.28 on 04/23/26 | 61.76 on 02/26/26 | 37.50 on 06/03/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 5,743,893 | 5,794,656 | 5,555,484 | ||
| Shares Outstanding, K | 310,985 | 96,449 | 185,740 | ||
| Annual Sales | 0 | 3,510,000 | 1,028,900,000 | ||
| Annual Net Income | -124,550,000 | -581,600,000 | -296,800,000 | ||
| Last Quarter Sales | 0 | 1,460,000 | 305,100,000 | ||
| Last Quarter Net Income | -183,440,000 | -122,930,000 | -54,300,000 | ||
| 60-Month Beta | 0.66 | 1.71 | 0.34 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.11 on 05/11/26 | -1.28 on 05/04/26 | -0.15 on 05/12/26 | ||
| Earnings Date | 08/11/26 | 08/03/26 | 08/10/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||